Legal Affairs

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...

Cronos Group Reports Q3 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...

Ohio to Award Dual-Use Cannabis Licenses by June

LOS ANGELES- Ohio is set to begin the transition to allow existing medical cannabis dispensaries to sell cannabis recreationally. The state's Joint Committee on Agency Rule Review has approved regulations for dual-use licenses, with applications ...

A Delays Hearing on Psychedelic Compounds

LOS ANGELES- The Drug Enforcement Administration (DEA) has postponed a crucial administrative hearing originally scheduled for June on the proposed ban of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision follows a legal ...

Cannabis Industry Licensing Trends

LOS ANGELES- The rapid expansion of the cannabis industry in North America has shown signs of cooling in the first quarter of 2024, with a noticeable decline in the number of both active licenses and ...

Subscribe To Our Newsletter